Clinical Trial Update: A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 [Phase 2]

View source ↗

Summary

Phase 2 study update evaluating Opregen for Geographic Atrophy due to Age-related Macular Degeneration, including optimization of subretinal surgical delivery a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• OpRegen

Snippet

Sponsor: Genentech, Inc. | Conditions: Geographic Atrophy | Phase 2 | Status: RECRUITING